In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Ligand Pharma (LGND – Research
Tag: Joseph Pantginis
Genocea Biosciences (GNCA) Receives a Buy from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Genocea Biosciences (GNCA – Research Report) today and set a
H.C. Wainwright Thinks Rigel’s Stock is Going to Recover
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Rigel (RIGL – Research Report),
H.C. Wainwright Thinks Aduro BioTech’s Stock is Going to Recover
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Aduro BioTech (ADRO – Research
Analysts Are Bullish on These Healthcare Stocks: Iovance Biotherapeutics Inc (IOVA), Vertex Pharmaceuticals (VRTX)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Iovance Biotherapeutics
H.C. Wainwright Thinks Fibrocell Science Inc’s Stock is Going to Recover
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Fibrocell Science Inc (FCSC – Research Report) today and set
Analysts’ Top Healthcare Picks: Rexahn Pharma (RNN), Nabriva (NBRV)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rexahn Pharma